Ubs Global Asset Management Americas »

Theravance Biopharma shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2023-12-31 $725k 65k 11.24
2023-09-30 $530k 61k 8.63
2023-06-30 $666k 61k 10.85
2023-03-31 $666k 61k 10.85
2022-12-31 $730k 65k 11.22
2022-09-30 $734k 72k 10.14
2022-06-30 $656k 72k 9.06
2022-03-31 $715k 75k 9.56
2021-12-31 $819k 74k 11.05
2021-09-30 $477k 65k 7.40
2021-06-30 $928k 64k 14.52
2021-03-31 $1.2M 61k 20.41
2020-12-31 $642k 43k 14.79
2020-09-30 $642k 43k 14.79
2020-06-30 $912k 43k 20.99
2020-03-31 $781k 34k 23.11
2019-12-31 $874k 34k 25.89
2019-09-30 $523k 27k 19.48
2019-06-30 $214k 13k 16.33
2019-03-31 $298k 13k 22.67
2018-12-31 $521k 20k 25.59
2018-09-30 $564k 17k 32.67
2018-06-30 $207k 9.1k 22.68
2018-03-31 $221k 9.1k 24.25
2017-12-31 $476k 17k 27.89
2017-09-30 $822k 24k 34.24
2017-06-30 $830k 21k 39.84
2017-03-31 $247k 6.7k 36.82
2016-12-31 $214k 6.7k 31.85
2016-09-30 $436k 12k 36.28
2016-06-30 $273k 12k 22.71
2015-03-31 $8.2M 472k 17.35
2014-12-31 $3.5M 234k 14.92
2014-09-30 $5.3M 231k 23.05
2014-06-30 $7.0M 221k 31.88